Journey Medical (DERM) Accumulated Expenses (2020 - 2026)

Journey Medical has reported Accumulated Expenses for 7 years, with the latest figure at $848000.0 in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Expenses fell 39.69% year-over-year to $848000.0; the trailing twelve-month figure through Mar 2026 stood at $848000.0 (down 39.69% YoY), and the FY2025 full-year result was $27.6 million, up 58.2% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $848000.0, down from $27.6 million in the prior quarter.
• The five-year high for Accumulated Expenses was $27.6 million in Q4 2025, with the low at $323000.0 in Q2 2024.
• Historically, Accumulated Expenses has averaged $7.2 million across 5 years, with a median of $2.6 million in 2022.
• Annual changes were most pronounced in 2022 — Accumulated Expenses surged 1047.16% — and 2025, when it tumbled 97.4%.
• Journey Medical's Accumulated Expenses stood at $2.6 million in 2022, then climbed by 28.44% to $3.4 million in 2023, then jumped by 416.45% to $17.4 million in 2024, then soared by 58.2% to $27.6 million in 2025, then slumped by 96.92% to $848000.0 in 2026.
• The last three Accumulated Expenses figures came in at $848000.0 (Q1 2026), $27.6 million (Q4 2025), and $416000.0 (Q3 2025), per Business Quant data.